https://www.indivior.com/our-company 2026-04-02 weekly 0.8 https://www.indivior.com/our-science 2026-03-24 weekly 0.8 https://www.indivior.com/our-products 2026-01-07 weekly 0.8 https://www.indivior.com/our-impact 2026-01-08 weekly 0.8 https://www.indivior.com/investors 2026-01-08 weekly 0.8 https://www.indivior.com/careers 2026-04-02 weekly 0.8 https://www.indivior.com/our-company/our-focus 2026-01-08 weekly 0.8 https://www.indivior.com/our-company/our-culture 2026-01-13 weekly 0.8 https://www.indivior.com/our-company/our-leadership 2026-02-05 weekly 0.8 https://www.indivior.com/our-science/our-scientific-leadership 2026-03-27 weekly 0.8 https://www.indivior.com/our-impact/patient-safety-and-product-quality 2026-02-24 weekly 0.8 https://www.indivior.com/our-impact/organizations-we-work-with 2026-03-31 weekly 0.8 https://www.indivior.com/site-services/privacy-notice 2025-12-20 weekly 0.8 https://www.indivior.com/site-services/cookies 2026-03-12 weekly 0.8 https://www.indivior.com/site-services/accessibility 2025-12-22 weekly 0.8 https://www.indivior.com/our-company/our-culture/raleigh 2026-04-02 weekly 0.8 https://www.indivior.com/our-company/our-culture/richmond 2026-04-02 weekly 0.8 https://www.indivior.com/international/australia 2026-04-02 weekly 0.8 https://www.indivior.com/international/canada-en 2026-04-02 weekly 0.8 https://www.indivior.com/international/french-canada 2026-04-02 weekly 0.8 https://www.indivior.com/international/denmark 2026-04-02 weekly 0.8 https://www.indivior.com/international/finland 2026-04-02 weekly 0.8 https://www.indivior.com/international/france 2026-04-02 weekly 0.8 https://www.indivior.com/international/germany 2026-04-02 weekly 0.8 https://www.indivior.com/international/israel 2026-04-02 weekly 0.8 https://www.indivior.com/international/italy 2026-04-02 weekly 0.8 https://www.indivior.com/international/norway 2026-01-21 weekly 0.8 https://www.indivior.com/international/sweden 2026-01-21 weekly 0.8 https://www.indivior.com/international/uk 2026-01-26 weekly 0.8 https://www.indivior.com/latest 2026-04-02 weekly 0.8 https://www.indivior.com/latest/category/financial-news 2026-04-02 weekly 0.8 https://www.indivior.com/latest/category/news/2026/indivior-announces-completion-of-redomiciliation-to-the-united-states 2026-01-29 weekly 0.8 https://www.indivior.com/latest/category/news/2026/indivior-to-participate-in-upcoming-investor-conferences 2026-02-24 weekly 0.8 https://www.indivior.com/latest/category/news/2026/indivior-reports-fourth-quarter-and-full-year-2025-financial-results 2026-02-26 weekly 0.8 https://www.indivior.com/latest/category/news/2026/indivior-announces-proposed-convertible-senior-notes-offering 2026-03-11 weekly 0.8 https://www.indivior.com/latest/category/news/2026/indivior-prices-upsized-450-million-convertible-senior-notes-offering 2026-03-13 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-proposes-new-corporate-structure-to-achieve-us-domiciliation 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2025/-20indivior-appoints-tony-kingsley-to-the-board-of-directors 2026-01-08 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-announces-patrick-barry-as-chief-commercial-officer 2026-01-08 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-announces-joseph-ciaffoni-appointed-chief-executive-officer 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-attends-the-ondcp-2024-oorm-manufacturers-meeting 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-provides-update-on-aelis-farmas-clinical-phase 2026-01-09 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-to-host-analyst-teach-in-event-in-new-york-city 2026-01-13 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indiviorplc-opvee-approval 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior_statement_on_the_availability_of_opvee_nalmefene_nasal_spray 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/additional-us-listing 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/board-appointment-barbara-ryan 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-announces-nina-delorenzo 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-sept22-conferences 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indv-2022-gm-approval 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indv-opnt-111422 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indv-cmd-2022 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/biden-ndcs 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/matact 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/board-appointments-and-succession-plan-announced 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/albatros 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/appointment-of-chief-financial-officer 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/appointment-of-nonexecutive-chair 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/indivior-takes-strategic-alignment-actions 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/indivior-plc-board-announcement 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/appointment-of-chief-executive-officer 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/directorate-change 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/virginia-tech-and-indivior-announce-new-collaboration 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-launches-national-campaign 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-directorate-changes 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indiviorplc-directors-change-of-responsiblities 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-announces-validation-of-marketing-authorization-application 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-announces-launch-of-suboxone 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/court-of-appeals-for-federal-circuit 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/court-of-appeals-for-federal-circuit-denies-motion-for-rehearsing 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-to-divest-interest-in-china 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-enters-into-agreement-with-alvogen 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/fda-posts-advisory-committee-meeting-notice-for-rbp-6000-nda 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/resignation-of-cary-clairborne-as-chief-financial-officer 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/chief-financial-officer-announcement 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-announces-health-canada-approval-of-sublocade 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-preliminary-injunction-on-generic-sublingual-film-upheld 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/fda-approves-perseris-for-extended-release-injectable-suspension 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/result-of-agm 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-announces-new-drug-submission-to-health-canada-for-sublocade 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/annual-report-and-accounts-2017-and-agm-2018 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-plc-the-company-directorate-change 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-announces-intention-to-list-adrs-in-us 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-plc-directorate-change-2016 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-inc-receives-a-paragraph-iv-notice-of-certification-letter 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/financial-news/2026/indivior-to-report-q4-and-fy2025-and-host-webcast-on-feb-26th 2026-01-29 weekly 0.8 https://www.indivior.com/latest/category/financial-news/2026/indivior-provides-fy-2026-financial-guidance-and-business-update 2026-03-17 weekly 0.8 https://www.indivior.com/ 2026-04-07 weekly 0.8 https://www.indivior.com/our-impact/ethical-business-practices 2026-04-07 weekly 0.8 https://www.indivior.com/latest/category/news/2026/new-study-shows-adherence-to-monthly-injectable-buprenorphine-linked-to-lower-healthcare-utilization-and-costs-in-opioid-use-disorder 2026-03-11 weekly 0.8 https://www.indivior.com/latest/category/news/2026/new-cost-impact-model-highlights-potential-for-monthly-injectable-buprenorphine-to-reduce-staffing-burdens-in-correctional-facilities 2026-03-31 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-appoints-vanessa-procter-as-executive-vice-president-of-corporate-affairs 2026-01-08 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-announces-completion-of-cancellation-of-secondary-listing-on-london-stock-exchange-primary-listing-on-nasdaq-to-be-maintained 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-announces-dosing-of-first-subject-with-indv-2000-in-a-phase-2-study-assessing-the-safety-and-efficacy-of-indv-2000-in-individuals-with-opioid-use-disorder 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2024/rapid-initiation-with-once-monthly-sublocade-superior-to-standard-initiation-csam-2024 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2026/only-58-percent-of-us-correctional-facilities-offer-medications-for-opioid-use-disorder 2026-03-17 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-announces-regulatory-submission-to-australias-therapeutic-goods-administration 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-announces-bardas-first-order-of-opvee-to-combat-opioids-and-aid-national-preparedness 2026-01-09 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-announces-launch-of-perseris-for-treatment-of-schizophrenia-in-adults 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/fda-approves-sublocade-the-first-and-only-once-monthly-injectable-buprenorphine-forumulation 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-and-addex-enter-strategic-collaboration-to-accelerate-development-of-gabab-pams-for-addiction-disorder-treatments 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indiviors-nalscue-receives-marketing-authorization-from-french-regulatory-agency-ansm 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-is-granted-temporary-restraining-order-on-generic-sublingual-film 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-announces-bardas-first-order-of-opvee-c2-ae-to-combat-opioids-and-aid-in-national-preparedness 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-applauds-biden-administrations-new-buprenorphine-practice-guidelines 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-opens-30-million-research-and-development-center-to-advance-treatment-innovation 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-provides-update-on-aelis-farma-s-clinical-phase-2b-study-results-with-aef0117-in-participants-with-cannabis-use-disorder 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-announces-nda-acceptance-of-rbp-7000-risperidone-monthly-depot 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-announces-fda-approval-of-label-changes-for-sublocade-injection 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-enters-into-exclusive-license-agreement-with-hls-therapeutics 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/indivior-receives-approval-for-subutex-prolonged-release-solution-for-injection 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-and-virginia-commonwealth-university-school-of-pharmacy-enter-academic-partnership 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-announces-the-publication-of-new-data-on-the-comparative-effectiveness-of-intranasal-nalmefene-and-in-naloxone-in-a-translational-model 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2017/fda-advisory-committees-recommend-approval-of-indiviors-rbp-6000-for-the-treatment-of-opioid-use-disorder 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-submits-new-drug-application-to-us-fda-for-rbp-6000-buprenorphine-monthly-depot 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-welcomes-white-house-announcement-prioritizing-expanded-access-to-evidence-based-treatment 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-submits-new-drug-application-to-us-fda-for-rbp-7000-risperidone-monthly-depot 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indiviors-sublocade-rapid-induction-alternative-injection-site-prior-approval-supplement 2026-01-09 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-receives-fda-fast-track-designation-for-rbp-6000-buprenorphine-monthly-depot-for-treatment-of-opioid-use-disorder 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior_plc_form_20-f_registration_statement_for_additional_us_listing 2025-12-29 weekly 0.8